Literature DB >> 3510223

Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome.

T Saruta, H Suzuki, M Handa, Y Igarashi, K Kondo, S Senba.   

Abstract

The mechanisms causing high blood pressure in patients with Cushing's syndrome were investigated by measurements of humoral factors and pharmacological maneuvers. Twelve patients with adrenal adenomas were studied. The mean systolic and diastolic pressures of the patients were 171 +/- 28 and 109 +/- 15 mm Hg (+/- SEM), respectively, which were significantly higher than those of normal subjects. PRA, plasma renin concentration, plasma renin substrate, plasma cortisol, plasma aldosterone, urinary kallikrein, and urinary prostaglandin E2 were measured as the humoral factors. PC values were markedly elevated in patients with Cushing's syndrome. Among the components of the renin-angiotensin system, only plasma renin substrate was increased. Urinary kallikrein and prostaglandin E2 were decreased in patients with Cushing's syndrome. Oral administration of captopril lowered blood pressure, but infusion of an angiotensin II analog did not. Furthermore, the pressor responses to infusion of both norepinephrine and angiotensin II were increased. We conclude that blood pressure is elevated in patients with Cushing's syndrome because they have enhanced pressor responses to vasoactive substances, suppression of depressor systems, and some abnormalities of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510223     DOI: 10.1210/jcem-62-2-275

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  25 in total

1.  Hormonal background of the hypertension and fluid derangements associated with adrenocorticotrophic hormone treatment of infants.

Authors:  R Riikonen; O Simell; L Dunkel; P Santavuori; J Perheentupa
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

2.  Role of endogenous serotonin in the regulation of blood pressure in patients with chronic renal failure.

Authors:  M Yamakado; M Nagano; M Umezu; H Tagawa; H Kiyose
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Atrial natriuretic peptide in Cushing's disease.

Authors:  G Opocher; S Rocco; G Carpenè; F Pedini; M Scarante; R Milani; M Boscaro; F Mantero
Journal:  J Endocrinol Invest       Date:  1990-02       Impact factor: 4.256

4.  Vascular endothelial growth factor (VEGF), prostaglandin E2(PGE2) and active renin in hypertension of adrenal origin.

Authors:  S Zacharieva; I Atanassova; M Orbetzova; G Kirilov; E Nachev; K Kalinov; R Shigarminova
Journal:  J Endocrinol Invest       Date:  2004-09       Impact factor: 4.256

Review 5.  Glucocorticoid excess and hypertension.

Authors:  Smita Baid; Lynnette K Nieman
Journal:  Curr Hypertens Rep       Date:  2004-12       Impact factor: 5.369

6.  Blood pressure in pediatric patients with Cushing syndrome.

Authors:  Maya B Lodish; Ninet Sinaii; Nicholas Patronas; Dalia L Batista; Meg Keil; Jonelle Samuel; Jason Moran; Somya Verma; Jadranka Popovic; Constantine A Stratakis
Journal:  J Clin Endocrinol Metab       Date:  2009-03-17       Impact factor: 5.958

7.  Cushing's syndrome: still a potential killing disease.

Authors:  P A Younge; D Shmidt; P G Wiles
Journal:  J R Soc Med       Date:  1995-03       Impact factor: 5.344

Review 8.  Pharmacological management of renal colic in the older patient.

Authors:  Blayne K Welk; Joel M H Teichman
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

9.  Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells.

Authors:  M Sakaue; B B Hoffman
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

Review 10.  Cardiovascular risk and mortality in patients with active and treated hypercortisolism.

Authors:  Dingfeng Li; Omar M El Kawkgi; Andres F Henriquez; Irina Bancos
Journal:  Gland Surg       Date:  2020-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.